These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35150962)

  • 1. Predictors of use and improvement in glycemic indices after initiating continuous glucose monitoring in real world: Data from Saudi Arabia.
    Alyusuf EY; Alharthi S; Alguwaihes AM; Jammah AA; Alfadda AA; Al-Sofiani ME
    Diabetes Metab Syndr; 2022 Feb; 16(2):102416. PubMed ID: 35150962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes.
    Edwards S; He X; Wang W; Poon JL; Meadows E; Price D; Johnson J; Wolpert H; Polonsky W
    Diabetes Technol Ther; 2022 Jan; 24(1):61-66. PubMed ID: 34524010
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
    Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
    Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data.
    Hohendorff J; Gumprecht J; Mysliwiec M; Zozulinska-Ziolkiewicz D; Malecki MT
    Diabetes Technol Ther; 2021 Aug; 23(8):577-585. PubMed ID: 33794101
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
    O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
    Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
    [No Abstract]   [Full Text] [Related]  

  • 14. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Patient-reported Satisfaction and Metabolic Outcomes Following Initiation of the Second Generation of Flash Glucose Monitoring in Patients with Type 1 Diabetes.
    Al Hayek A; Robert AA; Alzahrani WM; Al Dawish MA
    Curr Diabetes Rev; 2024; 20(4):e100823219628. PubMed ID: 37563819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp-A Ceiling Effect?
    Nagl K; Bozic I; Berger G; Tauschmann M; Blauensteiner N; Weimann K; Mader JK; Rami-Merhar B
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
    Raghinaru D; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2022 Dec; 24(12):868-872. PubMed ID: 35920822
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Glucose Variability and Interweek Variability Affects the Time to Stability of Continuous Glucose Monitoring-Derived Glycemic Indices.
    Rama Chandran S; Jacob P; Choudhary P
    Diabetes Technol Ther; 2020 Dec; 22(12):937-942. PubMed ID: 32223562
    [No Abstract]   [Full Text] [Related]  

  • 20. Flash Glucose Monitoring System facilitates sustainable improvements in glycemic control in patients with type 1 diabetes: A 12-month follow-up study in real life.
    Al Hayek AA; Alwin Robert A; Al Dawish MA
    Diabetes Metab Syndr; 2022 Oct; 16(10):102620. PubMed ID: 36150328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.